MedPath

CT Perfusion in the Prognostication of Cerebral High Grade Glioma

Not Applicable
Completed
Conditions
Glioblastoma Multiforme
Registration Number
NCT01923922
Lead Sponsor
Nova Scotia Health Authority
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
48
Inclusion Criteria

Inclusion Criteria:<br><br> - All patients, presenting with a newly detected brain lesion likely to be high grade<br> cerebral glioma either on CT or MRI of the brain<br><br>Exclusion Criteria:<br><br> - Pregnant patients<br><br> - those with impaired renal function

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Survival of patients with high grade cerebral glioma based on the CT perfusion parameters irrespective of the pathological grade and irrespective of the treatment given.
Secondary Outcome Measures
NameTimeMethod
Number of Adverse Events as a Measure of Safety and Tolerability
© Copyright 2025. All Rights Reserved by MedPath